Documents Which endpoint to choose ? (in phase II sarcoma clinical trials) George D. Demetri, MD Dana-Farber /...

Slide 1Which endpoint to choose ? (in phase II sarcoma clinical trials) George D. Demetri, MD Dana-Farber / Harvard Cancer Center, Boston Mass. USA for Robert Maki, MD PhD…

Documents 1 Chapter 11 Issues in Analysis of Randomized Clinical Trials.

Slide 11 Chapter 11 Issues in Analysis of Randomized Clinical Trials Slide 2 2 Issues in Analysis of Randomized Clinical Trials Reference: May, DeMets et al (1981) Circulation…

Documents 542-10-#1 Statistics 542 Introduction to Clinical Trials Issues in Analysis of Randomized Clinical.....

Slide 1542-10-#1 Statistics 542 Introduction to Clinical Trials Issues in Analysis of Randomized Clinical Trials Slide 2 542-10-#2 Issues in Analysis of Randomized Clinical…